Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:661-667
Published online before print February 27, 2003, doi: 10.1161/01.ATV.0000063614.21233.BF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/4/661    most recent
01.ATV.0000063614.21233.BFv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, S.-R.
Right arrow Articles by Husmann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, S.-R.
Right arrow Articles by Husmann, M.
Related Collections
Right arrow Lipids
Right arrow Gene expression
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:661.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Enzymatically Modified LDL Induces Cathepsin H in Human Monocytes

Potential Relevance in Early Atherogenesis

Shan-Rui Han; Arash Momeni*; Katharina Strach*; Prapat Suriyaphol; Dominic Fenske; Kerstin Paprotka; Shin Ichi Hashimoto; Michael Torzewski; Sucharit Bhakdi; Matthias Husmann

From the Institute of Medical Microbiology and Hygiene and Department for Clinical Chemistry and Laboratory Medicine (M.T.), Johannes Gutenberg-University Mainz, Germany, and Department of Molecular and Preventive Medicine and CREST (S.I.H.), School of Medicine, University of Tokyo, Japan.

Correspondence to M. Husmann, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University Mainz, Hochhaus am Augustusplatz, 55131 Mainz, Germany. E-mail MattHusmann{at}web.de

Objective— Modification with proteases and cholesterylesterase transforms LDL to a moiety that resembles lipoproteins isolated from atherosclerotic lesions and possesses atherogenic properties. To identify changes in monocyte-derived foam cells laden with enzymatically modified LDL (E-LDL), we compared patterns of the most abundant transcripts in these cells after incubation with LDL or E-LDL.

Methods and Results— Serial analyses of gene expression (SAGE) libraries were constructed from human monocytes after treatment with LDL or E-LDL. Several tags were differentially expressed in LDL-treated versus E-LDL–treated cells, whereby marked selective induction by E-LDL of cathepsin H was conspicuous. We show that cathepsin H is expressed in atherosclerotic lesions in colocalization with E-LDL. Furthermore, we demonstrate that LDL modified with cathepsin H and cholesterylesterase can confer onto LDL the capacity to induce macrophage foam cell formation and to induce cathepsin H.

Conclusions— Cathepsin H could contribute to the transformation of LDL to an atherogenic moiety; the process might involve a self-sustaining amplifying circle.


Key Words: enzymatically modified LDL • monocytes • foam cells • cathepsin H




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Torzewski, P. Suriyaphol, K. Paprotka, L. Spath, V. Ochsenhirt, A. Schmitt, S.-R. Han, M. Husmann, V. B. Gerl, S. Bhakdi, et al.
Enzymatic Modification of Low-Density Lipoprotein in the Arterial Wall: A New Role for Plasmin and Matrix Metalloproteinases in Atherogenesis
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2130 - 2136.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Bhakdi, M. Torzewski, K. Paprotka, S. Schmitt, H. Barsoom, P. Suriyaphol, S.-R. Han, K. J. Lackner, and M. Husmann
Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence
Circulation, April 20, 2004; 109(15): 1870 - 1876.
[Abstract] [Full Text] [PDF]